Back to Authors

Habermann, Thomas M.

https://orcid.org/0000-0003-3532-9132

A5025688165 | I1330342723

Mayo Clinic

Citations 663

Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6517-6519

10.1182/blood-2022-165419

Predictive Value of Staging PET/CT to Detect Bone Marrow Involvement in Marginal Zone Lymphoma (MZL): An Analysis from LEO MZL Working Group

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9340-9341

10.1182/blood-2022-162688

A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1307-1309

10.1182/blood-2022-167466

Molecular Landscape of Primary Refractory DLBCL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9221-9223

10.1182/blood-2022-156497

Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6642-6644

10.1182/blood-2022-157083

Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1742-1744

10.1182/blood-2022-159620

Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6489-6491

10.1182/blood-2022-167633

Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6426-6427

10.1182/blood-2022-160351

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3548-3550

10.1182/blood-2022-170228

FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2292-2295

10.1182/blood-2022-157194